BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND NUMA1, Q14980, 4926, ENSG00000137497, NUMA
28 results:

  • 1. LINC01194 recruits numa1 to promote ubiquitination of RYR2 to enhance malignant progression in triple-negative breast cancer.
    Zhai D; Zhang M; Li Y; Bi J; Kuang X; Shan Z; Shao N; Lin Y
    Cancer Lett; 2022 Sep; 544():215797. PubMed ID: 35750275
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Investigation of the SPAG5 gene expression and amplification related to the numa mRNA levels in breast ductal carcinoma.
    Mohamadalizadeh-Hanjani Z; Shahbazi S; Geranpayeh L
    World J Surg Oncol; 2020 Aug; 18(1):225. PubMed ID: 32838814
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The nuclear structural protein numa is a negative regulator of 53BP1 in DNA double-strand break repair.
    Salvador Moreno N; Liu J; Haas KM; Parker LL; Chakraborty C; Kron SJ; Hodges K; Miller LD; Langefeld C; Robinson PJ; Lelièvre SA; Vidi PA
    Nucleic Acids Res; 2019 Apr; 47(6):2703-2715. PubMed ID: 30812030
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines.
    Sharif-Askari B; Amrein L; Aloyz R; Panasci L
    Breast Cancer Res Treat; 2018 Nov; 172(1):23-32. PubMed ID: 30039287
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort.
    Lafourcade A; His M; Baglietto L; Boutron-Ruault MC; Dossus L; Rondeau V
    BMC Cancer; 2018 Feb; 18(1):171. PubMed ID: 29426294
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. BRCA1 controls the cell division axis and governs ploidy and phenotype in human mammary cells.
    He Z; Kannan N; Nemirovsky O; Chen H; Connell M; Taylor B; Jiang J; Pilarski LM; Fleisch MC; Niederacher D; Pujana MA; Eaves CJ; Maxwell CA
    Oncotarget; 2017 May; 8(20):32461-32475. PubMed ID: 28427147
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types.
    Fancello L; Kampen KR; Hofman IJ; Verbeeck J; De Keersmaecker K
    Oncotarget; 2017 Feb; 8(9):14462-14478. PubMed ID: 28147343
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Decreased Usage of Specific Scrib Exons Defines a More Malignant Phenotype of breast cancer With Worsened Survival.
    Metodieva G; Adoki S; Lausen B; Metodiev MV
    EBioMedicine; 2016 Jun; 8():150-158. PubMed ID: 27428426
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tankyrase as a Novel Molecular Target in cancer and Fibrotic Diseases.
    Lakshmi TV; Bale S; Khurana A; Godugu C
    Curr Drug Targets; 2017; 18(10):1214-1224. PubMed ID: 27425647
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ATM controls proper mitotic spindle structure.
    Palazzo L; Della Monica R; Visconti R; Costanzo V; Grieco D
    Cell Cycle; 2014; 13(7):1091-100. PubMed ID: 24553124
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genetic risk transmission in a family affected by familial breast cancer.
    Pilato B; De Summa S; Danza K; Lacalamita R; Lambo R; Sambiasi D; Paradiso A; Tommasi S
    J Hum Genet; 2014 Jan; 59(1):51-3. PubMed ID: 24152768
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The BRCA1-binding protein BRAP2 can act as a cytoplasmic retention factor for nuclear and nuclear envelope-localizing testicular proteins.
    Davies RG; Wagstaff KM; McLaughlin EA; Loveland KL; Jans DA
    Biochim Biophys Acta; 2013 Dec; 1833(12):3436-3444. PubMed ID: 23707952
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. numa is required for the selective induction of p53 target genes.
    Ohata H; Miyazaki M; Otomo R; Matsushima-Hibiya Y; Otsubo C; Nagase T; Arakawa H; Yokota J; Nakagama H; Taya Y; Enari M
    Mol Cell Biol; 2013 Jun; 33(12):2447-57. PubMed ID: 23589328
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer.
    Rosa-Rosa JM; Pita G; González-Neira A; Milne RL; Fernandez V; Ruivenkamp C; van Asperen CJ; Devilee P; Benitez J
    Breast Cancer Res Treat; 2009 Nov; 118(1):151-9. PubMed ID: 19205878
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Linkage disequilibrium mapping of a breast cancer susceptibility locus near RAI/PPP1R13L/iASPP.
    Nexø BA; Vogel U; Olsen A; Nyegaard M; Bukowy Z; Rockenbauer E; Zhang X; Koca C; Mains M; Hansen B; Hedemand A; Kjeldgaard A; Laska MJ; Raaschou-Nielsen O; Cold S; Overvad K; Tjønneland A; Bolund L; Børglum AD
    BMC Med Genet; 2008 Jun; 9():56. PubMed ID: 18588689
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comprehensive analysis of numa variation in breast cancer.
    Kilpivaara O; Rantanen M; Tamminen A; Aittomäki K; Blomqvist C; Nevanlinna H
    BMC Cancer; 2008 Mar; 8():71. PubMed ID: 18331640
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The control of tissue architecture over nuclear organization is crucial for epithelial cell fate.
    Chandramouly G; Abad PC; Knowles DW; Lelièvre SA
    J Cell Sci; 2007 May; 120(Pt 9):1596-606. PubMed ID: 17405811
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A common coding variant in CASP8 is associated with breast cancer risk.
    Cox A; Dunning AM; Garcia-Closas M; Balasubramanian S; Reed MW; Pooley KA; Scollen S; Baynes C; Ponder BA; Chanock S; Lissowska J; Brinton L; Peplonska B; Southey MC; Hopper JL; McCredie MR; Giles GG; Fletcher O; Johnson N; dos Santos Silva I; Gibson L; Bojesen SE; Nordestgaard BG; Axelsson CK; Torres D; Hamann U; Justenhoven C; Brauch H; Chang-Claude J; Kropp S; Risch A; Wang-Gohrke S; Schürmann P; Bogdanova N; Dörk T; Fagerholm R; Aaltonen K; Blomqvist C; Nevanlinna H; Seal S; Renwick A; Stratton MR; Rahman N; Sangrajrang S; Hughes D; Odefrey F; Brennan P; Spurdle AB; Chenevix-Trench G; ; Beesley J; Mannermaa A; Hartikainen J; Kataja V; Kosma VM; Couch FJ; Olson JE; Goode EL; Broeks A; Schmidt MK; Hogervorst FB; Van't Veer LJ; Kang D; Yoo KY; Noh DY; Ahn SH; Wedrén S; Hall P; Low YL; Liu J; Milne RL; Ribas G; Gonzalez-Neira A; Benitez J; Sigurdson AJ; Stredrick DL; Alexander BH; Struewing JP; Pharoah PD; Easton DF;
    Nat Genet; 2007 Mar; 39(3):352-8. PubMed ID: 17293864
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Automated local bright feature image analysis of nuclear protein distribution identifies changes in tissue phenotype.
    Knowles DW; Sudar D; Bator-Kelly C; Bissell MJ; Lelièvre SA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4445-50. PubMed ID: 16537359
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Caspase-3 is required in the apoptotic disintegration of the nuclear matrix.
    Kivinen K; Kallajoki M; Taimen P
    Exp Cell Res; 2005 Nov; 311(1):62-73. PubMed ID: 16199031
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.